Skip to main content

Contrast Media and Interactions with Other Drugs and Clinical Tests

  • Chapter
Contrast Media

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

Abstract

Water soluble contrast media may interfere with the pharmacokinetics or pharmacodynamics of other drugs, as well as with some biochemical assays and with isotope imaging. These topics are reviewed in this chapter, with the aim of raising the awareness of both radiologists and clinicians to the possibility of these problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abi-Aad AS, Figlin RA, Belldegrun A, de Kernion JB (1991) Metastatic renal cell cancer: Interleukin-2 toxicity induced by contrast agent injection. J Immun 10:292–295

    Article  CAS  Google Scholar 

  • Barrs TJ (2002) Establishing safeguards for the use of imaging related drugs. Am J Health Syst Pharm 59:1449–1553

    PubMed  Google Scholar 

  • Choyke PL, Miller DL, Lotze MT et al (1992) Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 183:111–114

    CAS  PubMed  Google Scholar 

  • Choyke PL, Knopp MV (2003) Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale. Radiology 227:627–628

    Article  PubMed  Google Scholar 

  • Crawford JA, Gumerman LW (1978) Alteration of body distribution of Tc99 m-pyrophosphate by radiographic contrast material. Clin Nucl Med 3:305–307

    Article  CAS  PubMed  Google Scholar 

  • Dehmer GJ, Gresalfi N, Daly D et al (1995) Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol 25:1069–1075

    Article  CAS  PubMed  Google Scholar 

  • Fischer HW, Morris TW (1980) Possible factors in intravascular contrast media toxicity. Invest Radiol 15(Suppl 6): S232–S238

    Google Scholar 

  • Frohlich JM (2001) Systematic survey of interactions between contrast media and other drugs, Special edition by Guerbet Switzerland

    Google Scholar 

  • Greenberg PA, Myers SN, Kramer BL et al (1987) Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media. J Allergy Clin Immunol 80:698–702

    Article  Google Scholar 

  • Harned TM, Mascarenhas L (2007) Severe methotrexate toxicity precipitated by intravenous radiographic contrast. Clin Lab Observ 29:496–499

    CAS  Google Scholar 

  • Higgins CB, Kruber M, Slutsky RA (1983) Interaction between verapamil and contrast media in coronary arteriography: comparison of standard ionic and new nonionic media. Circulation 68:628–635

    Article  CAS  PubMed  Google Scholar 

  • Kim SH, Lee HK, Han MC (1992) Incompatibility of water-soluble contrast media and intravascular pharmacologic agents. An in vitro study. Invest Radiol 27:45–49

    Article  CAS  Google Scholar 

  • Jakobsen JÃ…, Oyen R, Thomsen HS, Morcos SK, members of Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (2005) Safety of ultrasound contrast media. Eur Radiol 15:941–945

    Google Scholar 

  • Junge W, Troge B (1991) Kontrastmittel als Störfaktoren in der laborchemischen analytik. In: Peters PE, Zetler E (eds) Röntgen Kontrastmittel. Springer, Berlin, pp 76–82

    Google Scholar 

  • Laurence DR, Bennett PN (1992) Clinical pharmacology, 7th edn. Churchill Livingstone, Edinburgh, pp 416–423

    Google Scholar 

  • Lang DM, Alpern MB, Visintainer PF, Smith ST (1991) Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med 115:270–276

    Article  CAS  PubMed  Google Scholar 

  • Lang DM, Alpern MB, Visintainer PF, Smith ST (1993) Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 153:2033-2040. Erratum in Arch Intern Med 153:2412

    Article  Google Scholar 

  • Massee DR, Smith DC, Westengard JC, Bull BS (1991) Heparin supplementation of nonionic contrast agents. J Vasc Interv Radiol 2:209–213

    Article  CAS  PubMed  Google Scholar 

  • Morcos SK (1998) Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71:357–365

    CAS  PubMed  Google Scholar 

  • Morcos SK, Dawson P, Pearson JD et al (1998) The hemodynamic effects of iodine-based water soluble radiographic contrast media: a review. Eur J Radiol 29:31–46

    Article  CAS  PubMed  Google Scholar 

  • Morcos SK, El Nahas AM, Brown P, Haylor J (1992) Effect of iodinated water soluble contrast media on urinary protein assays. BMJ 305:29

    Article  CAS  PubMed  Google Scholar 

  • Morcos SK, Thomsen HS, Webb JAW, ESUR Contrast Media Safety Committee (1999) Contrast media-induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613

    Google Scholar 

  • Morcos SK, Thomsen HS, ESUR Contrast Media Safety Committee (2005). Contrast media: Interactions with other drugs and clinical tests. Eur Radiol 15:1607–1614

    Google Scholar 

  • Morris DL, Wisneski JA, Gertz EW et al (1985) Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography. J Am Coll Cardiol 6:785–791

    Article  CAS  PubMed  Google Scholar 

  • Normann PT, Frøysa A, Svaland M (1995) Interference of gadodiamide injection (OMNISCAN®) on the colorimetric determination of serum calcium. Scand J Clin Lab Invest 55:421–426

    Article  CAS  PubMed  Google Scholar 

  • Parvez Z, Moncada R, Messmore HL, Fareed J (1982) Ionic and non-ionic contrast media interaction with anticoagulant drugs. Acta Radiol Diagn (Stockh) 23:401–404

    CAS  Google Scholar 

  • Pislaru S, Pislaru C, Szilard M et al (1998) In vivo effects of contrast media on coronary thrombolysis. J Am Coll Cardiol 32:1102–1108

    Article  CAS  PubMed  Google Scholar 

  • Prince MR, Erel HE, Lent RW et al (2003) Gadodiamide administration causes spurious hypocalcemia. Radiology 227:639–646

    Article  PubMed  Google Scholar 

  • Proctor KAS, Rao LV, Roberts WL (2004) Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays. Am J Clin Pathol 121:282–292

    Article  PubMed  Google Scholar 

  • Reynolds N, Wallington TB, Burton JL (1993) Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol. Br J Dermatol 129:82–85

    Article  CAS  PubMed  Google Scholar 

  • Swanson DP, Chilton HM, Thrall JH (eds) (1990) Pharmaceuticals in medical imaging: radiopaque contrast media, radiopharmaceuticals, enhancement agents for magnetic resonance imaging and ultrasound. Macmillan. New York, Toronto, p 42

    Google Scholar 

  • Tatum JL, Burke TS, Hirsch JI et al (1983) Pitfall to modified in vivo method of technetium-99 m red blood cell labeling Iodinated contrast media. Clin Nucl Med 8:585–587

    Article  CAS  PubMed  Google Scholar 

  • Thomsen HS, Morcos SK, ESUR Contrast Media Safety Committee (1999) Contrast media and metformin. Guidelines to diminish the risk of lactic acidosis in noninsulin dependent diabetics after administration of contrast media. Eur Radiol 9:738–740

    Google Scholar 

  • Thomsen HS, Morcos SK (2003) Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76:513–551

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sameh K. Morcos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Morcos, S.K. (2014). Contrast Media and Interactions with Other Drugs and Clinical Tests. In: Thomsen, H., Webb, J. (eds) Contrast Media. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_889

Download citation

  • DOI: https://doi.org/10.1007/174_2013_889

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-36723-6

  • Online ISBN: 978-3-642-36724-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics